Contribution of activated C3 to lymphocyte-mediated cytolysis

Generation of cytotoxicity with various MHC class I restrictions against autologous LCL by stimulating the lymphocytes with autologous and/or allogeneic LCLs sharing HLA alleles with the responder.

Cellular immunology·1992

HLA-B5-restricted auto-tumor-specific cytotoxic T cells generated in mixed lymphocyte-tumor-cell culture.

International journal of cancer·1992

A trypsin-like serine protease activity on activated human B cells and various B cell lines.

European journal of immunology·1992

Characteristic ionic composition of endolymph is maintained in cultured inner ear.

Acta oto-laryngologica·1992

MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).

International journal of cancer·1992

Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-gamma or by a binding peptide.

Cellular immunology·1992

Pristimerin suppresses the phenotypic switch of vascular smooth muscle cells in atherosclerosis through inhibiting the activation of JAK2/STAT3 pathway.

Molecular immunology·2026

PD-L1 upregulated by IGF1R via the PI3K/AKT/NF-κB axis induces sorafenib resistance in hepatocellular carcinoma.

Molecular immunology·2026

Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.

Molecular immunology·2026

Exploring the relationship between natural and cryptic polyreactivity in human antibodies.

Molecular immunology·2026

Artemisinin ameliorates experimental autoimmune prostatitis by suppressing NLRP3 inflammasome-induced pyroptosis via the Nrf2/HO-1 axis.

Molecular immunology·2026

STK39 interacts with MAPK14 to facilitate cardiomyocyte pyroptosis in septic cardiomyopathy by inducing NLRP3 inflammasome.

Molecular immunology·2026

Long-term outcome of pediatric anti-complement factor H antibody-associated atypical hemolytic uremic syndrome receiving abbreviated plasma exchange: a retrospective study from a single center.

Journal of nephrology·2026

[Therapeutic apheresis in first-line treatment of hematological disorders - an evidence-based review].

Therapeutische Umschau. Revue therapeutique·2026

Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

Transfusion·2026

Platelet-erythrocyte complex production is exacerbated by histones and protected by small polyanion histone neutralizing compounds.

Platelets·2026

Changing the treatment paradigm in beta thalassemia.

Folia medica·2026

Noninvasive Thrombus Imaging in Patients With Ischemic Stroke.

Circulation·2026

Related Experiment Videos

Contribution of activated C3 to lymphocyte-mediated cytolysis

Related Concept Videos

Generation of cytotoxicity with various MHC class I restrictions against autologous LCL by stimulating the lymphocytes with autologous and/or allogeneic LCLs sharing HLA alleles with the responder.

HLA-B5-restricted auto-tumor-specific cytotoxic T cells generated in mixed lymphocyte-tumor-cell culture.

A trypsin-like serine protease activity on activated human B cells and various B cell lines.

Characteristic ionic composition of endolymph is maintained in cultured inner ear.

MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).

Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-gamma or by a binding peptide.

Pristimerin suppresses the phenotypic switch of vascular smooth muscle cells in atherosclerosis through inhibiting the activation of JAK2/STAT3 pathway.

PD-L1 upregulated by IGF1R via the PI3K/AKT/NF-κB axis induces sorafenib resistance in hepatocellular carcinoma.

Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.

Exploring the relationship between natural and cryptic polyreactivity in human antibodies.

Artemisinin ameliorates experimental autoimmune prostatitis by suppressing NLRP3 inflammasome-induced pyroptosis via the Nrf2/HO-1 axis.

STK39 interacts with MAPK14 to facilitate cardiomyocyte pyroptosis in septic cardiomyopathy by inducing NLRP3 inflammasome.

Long-term outcome of pediatric anti-complement factor H antibody-associated atypical hemolytic uremic syndrome receiving abbreviated plasma exchange: a retrospective study from a single center.

[Therapeutic apheresis in first-line treatment of hematological disorders - an evidence-based review].

Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

Platelet-erythrocyte complex production is exacerbated by histones and protected by small polyanion histone neutralizing compounds.

Changing the treatment paradigm in beta thalassemia.

Noninvasive Thrombus Imaging in Patients With Ischemic Stroke.

Related Experiment Videos

Contribution of activated C3 to lymphocyte-mediated cytolysis

Related Concept Videos

Related Articles